Zurueck zur Suche

Reporte zur Charge U6745AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

10Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
WA 2 NV 1 OH 1 PA 1 AZ 1 ID 1 AR 1 UT 1

VAERS 1536615

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge u6745aa

schwer
Staat
NV
Alter
17,0
Geschlecht
F
Eingang
09.08.2021
Impfdatum
09.08.2021
Beginn
09.08.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Syncope

Symptomtext

Vasovagal syncope, came to within a few second. No medical intervention needed. Parent was present.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
PCN
Vorherige Impfungen
HPV 6/9/2016

VAERS 951595

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U6745AA

schwer
Staat
OH
Alter
14,0
Geschlecht
M
Eingang
17.01.2021
Impfdatum
17.01.2021
Beginn
17.01.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Confusional state Fall Immediate post-injection reaction Pallor Syncope

Symptomtext

Pt experienced syncope within a minute after receiving the vaccine and fell off the exam table. He had pallor and was a bit confused at first. Was oriented x 4 within 1-2 minutes after the syncope. It took about 30 minutes before he was able to walk out of the exam room.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Syncope
Hospital-Tage
-
Labordaten
I checked his blood pressure a few times. It was about 100/58 shortly after the syncope while he was still laying down. Eventually was 110/70 before he sat up and maintained around that range.
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2585870

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U6745AA

moderat
Staat
PA
Alter
11,0
Geschlecht
M
Eingang
23.02.2023
Impfdatum
11.08.2020
Beginn
01.09.2020
Tage bis Beginn
21,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Arthralgia Back pain Blood urine present Condition aggravated Contusion Eosinophil percentage Fatigue Full blood count abnormal Haemoglobin normal Haemorrhage Hypersensitivity Illness Immune thrombocytopenia Loss of personal independence in daily activities Mean cell volume normal Mean platelet volume increased Monocyte count increased Monocyte percentage increased

Symptomtext

Malignancy; Intermittent knee pain; Petechiae bilateral lower extremities, petechial rash; Intermittent back pain; MPV high; Increased brusing, several bruises; Viral illness; Nasal congestion; Low iron saturation (5%); Persistent severe thrombocytopenia/ Consumptive thrombocytopenia; allergy; Low grade fever; bleeding symptoms; Platelet count of 8, significantly/critical low; Chronic persistent ITP; Severe fatigue, sleeping, Crushing fatigue; Falling asleep; Runny nose; This case was reported by a nurse via other and described the occurrence of thrombocytopenia in a 13-year-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number 4F99G, expiry date unknown) for prophylaxis. Co-suspect products included MENACTRA (batch number U6745AA, expiry date unknown) for prophylaxis. The patient's past medical history included headache (improved after eyeglasses or hydration), pneumonia (at 6 years old), iron deficiency (without anemia), idiopathic thrombocytopenic purpura and fatigue. On 11th August 2020, the patient received Boostrix and MENACTRA. In September 2020, between 1 and 2 months after receiving Boostrix, the patient experienced fatigue and sleepiness. In May 2021, the patient experienced runny nose. On 21st May 2021, the patient experienced idiopathic thrombocytopenic purpura (serious criteria GSK medically significant). On 20th September 2021, the patient experienced platelets decreased. In August 2022, the patient experienced symptomatic bleeding (serious criteria GSK medically significant) and low grade fever. On an unknown date, the patient experienced thrombocytopenia (serious criteria GSK medically significant), neoplasm malignant (serious criteria GSK medically significant), knee pain, petechia, back pain, mean platelet volume increased, contusion, viral infection, nasal congestion, iron saturation decreased and allergy. The patient was treated with famotidine, prednisone, polysaccharide-iron complex (Iron Polysaccharide), vitamins nos (Multivitamin), eltrombopag olamine (Promacta), eltrombopag, iron (Iron Supplement), iron sucrose (Iron Sucrose Iv) and steroids nos (Steroids). On an unknown date, the outcome of the thrombocytopenia, idiopathic thrombocytopenic purpura, neoplasm malignant, symptomatic bleeding, sleepiness, runny nose, knee pain, petechia, back pain, platelets decreased, mean platelet volume increased, contusion, viral infection, nasal congestion, iron saturation decreased, low grade fever and allergy were recovered/resolved and the outcome of the fatigue was recovering/resolving. It was unknown if the reporter considered the thrombocytopenia, idiopathic thrombocytopenic purpura, neoplasm malignant, symptomatic bleeding, fatigue, sleepiness, runny nose, knee pain, petechia, back pain, platelets decreased, mean platelet volume increased, contusion, viral infection, nasal congestion, iron saturation decreased, low grade fever and allergy to be related to Boostrix. Additional Information: GSK receipt date: 13-FEB-2023 Reporter's comment: The patients past medical history includes iron deficiency without anemia, chronic ITP and low iron stores. The patient had history of headache and minor fatigue since pneumonia episode at 6 years old. The patient received boostrix and menactra vaccine. In September or October 2020 crushing fatigue starts and falling asleep in school, in bus, on the was to and from hockey practice and some minor bruising noted from sports and fatigue improves when pits. In Jan to April 2021 occasional increased bruising. The petechia noticed on BLE when taking of hockey skates during the season and it was from tight skates. On 20th may 2021 BLE petechia noticed after being outside in short playing and patient did the lab test in may 2021. This was after 1-2 days of allergy sniffles. The patient was presented in emergency department due to petechlae and found to had platelet of 8. The patients both thighs had dense petechiea and noticed that there were also some on patients arm. The next day patients mom took to the pediatrician who got lab work in order to evaluate. The patients had a CBC were notable for a platelet count 8 with no other cell lines significantly down. Due to that patient brought to emergency department. The earlier this week patient had 2 days of runny nose without fever. The patient did not had hematuria but had 2 blood on urinalysis at patients mom. The patient had some intermittent keen and back pain over the past couple of months but nothing sustained and all were now gone. The patients presentation was somewhat atypical for ITP given there was no overt illness preceding the petechial rash. The history of nasal congestion over the last several days and there may had sub acute viral illness and the patient was not aware of it. The patient ferritin low normal at 30 not consistent with iron deficiency. The hemoglobin normal for age with normal MCV. The reporter was pleasure of meeting with patients mother for follow up of immune thrombocytopenia purpura. The patient was diagnosed with acute ITP on 21st May 2021 with platelet count of 8000. the patient was continued to gad severe thrombocytopenia (Platelets dropping to less than 10k) and treated with prednisone 20 mg BID for 5 days in July, August and September 2021. The patient also continued to had petechlae, increased brusing and fatigue that worsened when platelet count dropped. The patient was started promacta on 2nd Oct 2021 with initial dose 50 mg to 75 mg daily in order to maintain platelet count within goal and would experience petechia, increased brusing and a drop in platelet count with viral illnesses. The dose of promacta dose was adjusted based on count with overall best response at 50 mg. The patients hockey was on hold beginning late march and promacta dose was gradually decreased. On April 2022 promacta decreased to 37.5 mg daily and then 25 mg daily. On July 2022 platelets dropped to less than 20k and promacta increased to 50mg on 3rd Aug 2022. On August 2022 platelet count at 7k with bleeding symptoms and low grade fever. The promacta 50 mg and prednisone 20 mg bid improved platelets to 176k. The patients platelet count remained variable and dropping rapidly. The patient also improved with resolution of his viral illness and adjustment to promacta dose and most recently brief treatment with low dose steroids. The patient was now doing well with most recent platelet count 464 29 December 2022. The patient did not had current sings and symptoms of bleeding, bruising and petechiae and had restarted hockey with increased levels of activity this year and very low threshold to check platelet counts with any mild viral symptoms. It was unknown if the reporter considered the thrombocytopenia, idiopathic thrombocytopenic purpura, neoplasm malignant, symptomatic bleeding, fatigue, sleepiness, runny nose, knee pain, petechia, back pain, platelets decreased, mean platelet volume increased, contusion, viral infection, nasal congestion, iron saturation decreased and low grade fever to be related to menactra.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Condition aggravated
Hospital-Tage
-
Labordaten
Test Date: 20210521; Test Name: blood pressure; Result Unstructured Data: (Test Result:114/65,Unit:mmHg,Normal Low:,Normal High:); Test Date: 20210521; Test Name: body temperature; Result Unstructured Data: (Test Result:37,Unit:degree C,Normal Low:,Normal High:); Test Date: 20210521; Test Name: Eosinophils; Test Result: 4 %; Test Date: 20210521; Test Name: Haemoglobin; Result Unstructured Data: (Test Result:13.4,Unit:g/dL,Normal Low:,Normal High:); Test Date: 20220909; Test Name: Haemoglobin; Result Unstructured Data: (Test Result:14.1,Unit:g/dL,Normal Low:,Normal High:); Test Date: 20210521; Test Name: Pulse; Result Unstructured Data: (Test Result:58,Unit:beats/min,Normal Low:,Normal High:); Test Date: 20220909; Test Name: mean corpuscular volume; Result Unstructured Data: (Test Result:85.5,Unit:unknown,Normal Low:,Normal High:); Test Date: 20210521; Test Name: mean platelet volume; Result Unstructured Data: (Test Result:11.1,Unit:unknown,Normal Low:,Normal High:) 11.1fL; Test Date: 20210521; Test Name: ABS monocytes; Result Unstructured Data: (Test Result:1.10,Unit:unknown,Normal Low:,Normal High:) High; Test Date: 20210521; Test Name: Monocytes; Test Result: 19 %; Test Date: 20210521; Test Name: SpO2; Test Result: 100 %; Test Date: 20190610; Test Name: platelet count; Result Unstructured Data: (Test Result:250,Unit:unknown,Normal Low:,Normal High:) 250K; Test Date: 20200818; Test Name: platelet count; Result Unstructured Data: (Test Result:208,Unit:unknown,Normal Low:,Normal High:) 208K; Test Date: 20210521; Test Name: platelet count; Result Unstructured Data: (Test Result:8,Unit:unknown,Normal Low:,Normal High:) 8K; Test Date: 20210525; Test Name: platelet count; Result Unstructured Data: (Test Result:34,Unit:unknown,Normal Low:,Normal High:) 34K; Test Date: 20210602; Test Name: platelet count; Result Unstructured Data: (Test Result:19,Unit:unknown,Normal Low:,Normal High:) 19K; Test Date: 20210609; Test Name: platelet count; Result Unstructured Data: (Test Result:10,Unit:unknown,Normal Low:,Normal High:) 10K; Test Date: 20210614; Test Name: platelet count; Result Unstructured Data: (Test Result:16,Unit:unknown,Normal Low:,Normal High:) 16K; Test Date: 20210702; Test Name: platelet count; Result Unstructured Data: (Test Result:12,Unit:unknown,Normal Low:,Normal High:) 12K; Test Date: 20210708; Test Name: platelet count; Result Unstructured Data: (Test Result:99,Unit:unknown,Normal Low:,Normal High:) 99K; Test Date: 20210715; Test Name: platelet count; Result Unstructured Data: (Test Result:18,Unit:unknown,Normal Low:,Normal High:) 18K; Test Date: 20210728; Test Name: platelet count; Result Unstructured Data: (Test Result:28,Unit:unknown,Normal Low:,Normal High:) 28K; Test Date: 20210804; Test Name: platelet count; Result Unstructured Data: (Test Result:7,Unit:unknown,Normal Low:,Normal High:) 7K; Test Date: 20210811; Test Name: platelet count; Result Unstructured Data: (Test Result:32,Unit:unknown,Normal Low:,Normal High:) 32K; Test Date: 20210823; Test Name: platelet count; Result Unstructured Data: (Test Result:15,Unit:unknown,Normal Low:,Normal High:) 15K; Test Date: 20210830; Test Name: platelet count; Result Unstructured Data: (Test Result:15,Unit:unknown,Normal Low:,Normal High:) 15K; Test Date: 20210907; Test Name: platelet count; Result Unstructured Data: (Test Result:7,Unit:unknown,Normal Low:,Normal High:) 7K; Test Date: 20210920; Test Name: platelet count; Result Unstructured Data: (Test Result:8,Unit:unknown,Normal Low:,Normal High:) 8K; Test Date: 20211007; Test Name: platelet count; Result Unstructured Data: (Test Result:20,Unit:unknown,Normal Low:,Normal High:) 20K; Test Date: 20220909; Test Name: platelet count; Result Unstructured Data: (Test Result:464,Unit:unknown,Normal Low:,Normal High:) 464K; Test Date: 20210521; Test Name: RBC; Result Unstructured Data: (Test Result:3,Unit:unknown,Normal Low:,Normal High:) 3/HPF; Test Date: 20210521; Test Name: respiratory rate; Result Unstructured Data: (Test Result:18,Unit:unknown,Normal Low:,Normal High:) 18 br/min; Test Date: 20210521; Test Name: Ferritin; Test Result: 30.4 %; Test Date: 20210920; Test Name: Ferritin; Test Result: 22 %; Test Date: 20220128; Test Name: Ferritin; Test Result: 10.5 %; Test Date: 20220613; Test Name: Ferritin; Test Result: 12.3 %; Test Date: 202208; Test Name: Ferritin; Test Result: 124 %; Test Date: 20210920; Test Name: Iron saturation; Test Result: 11 %; Test Date: 20220128; Test Name: Iron saturation; Test Result: 10.5 %; Test Date: 20220613; Test Name: Iron saturation; Test Result: 12 %; Test Date: 202208; Test Name: Iron saturation; Test Result: 36 %; Test Date: 20210521; Test Name: Low iron saturation; Test Result: 5 %; Test Date: 20210521; Test Name: Hyaline casts; Result Unstructured Data: (Test Result:0,Unit:unknown,Normal Low:,Normal High:)
Aktuelle Erkrankungen
-
Vorgeschichte
Medical History/Concurrent Conditions: Fatigue; Headache (improved after eyeglasses or hydration); Idiopathic thrombocytopenic purpura; Iron deficiency (without anemia); Pneumonia (at 6 years old)
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1697932

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U6745AA

mild
Staat
WA
Alter
18,0
Geschlecht
M
Eingang
14.09.2021
Impfdatum
13.09.2021
Beginn
13.09.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration Pain in extremity

Symptomtext

Dose was administered subcutaneously instead of intramuscularly . Contacted Sanofi manufacturer and representative stated that the vaccine may not be as efficacious since it was administered incorrectly. I contacted the patient to let him know of the incorrect administration site and offered to readminister vaccine correctly free of charge. Patient asked if it is necessary to get the vaccine again and stated he will not be able to come in to get a new dose. Patient reported having a sore arm but mentioned the site of reaction did not appear red, irritated, or itchy.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
n/a
Andere Medikamente
None
Allergien
No known food or drug allergies
Vorherige Impfungen
-

VAERS 1515790

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U6745AA

mild
Staat
AZ
Alter
12,0
Geschlecht
M
Eingang
30.07.2021
Impfdatum
30.07.2021
Beginn
30.07.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Vomiting

Symptomtext

Pt became dizzy and started vomiting lasted for less than five minutes. After drinking water and sitting for another 5 min he felt better.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 1087474

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U6745AA

mild
Staat
-
Alter
18,0
Geschlecht
M
Eingang
10.03.2021
Impfdatum
07.03.2021
Beginn
07.03.2021
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Dizziness Fall Gait disturbance Nervousness

Symptomtext

After receiving vaccine and walking out clinic, patient stumbled, falling against door and to floor. Did not lose consciousness, reported feeling "lightheaded." Patient was placed on exam table in lying position with legs elevated. Provided water. After several minutes patient felt better to sit up. Fully recovered and stable on discharge. After event patient did report similar reactions in the past to blood draws but never a vaccine. Patient did report after the fact that he was nervous coming in.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 985777

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U6745AA

mild
Staat
ID
Alter
16,0
Geschlecht
M
Eingang
29.01.2021
Impfdatum
24.01.2021
Beginn
25.01.2021
Tage bis Beginn
1,0
Dosis
2
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Back pain Pain in extremity

Symptomtext

Pain develop in upper back day after vaccination and has now spread to legs

Weitere VAERSDATA-Felder
Praegender Schweregrund
Back pain
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
HAD A FEW SYMPTOMS OF COVID-19 COUPLE WEEKS PRIOR BUT COVID-19 TEST WAS NEGATIVE
Vorgeschichte
NEUROFIBROMATOSIS
Andere Medikamente
ARIPIPRAZOLE 15MG (1/2 TAB QD) BACTRIM DS 800MG-160MG (1 TAB QD) FLUOXETINE 60MG (1 TAB QHS)
Allergien
NONE
Vorherige Impfungen
-

VAERS 1813075

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U6745AA

gering
Staat
AR
Alter
16,0
Geschlecht
M
Eingang
23.10.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Expired product administered No adverse event

Symptomtext

a new nurse at the practice administered vaccine had expired with no A/E; Initial information was received on 14-Oct-2021 regarding an unsolicited valid non-serious case received via an other health professional via consumer via phone call. This case involves a 16-years old male patient who was administered with an expired dose of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] by a new nurse at the practice with no reported adverse event (expired product administered). The patient's medical history, past medical treatments, concomitant medications, vaccinations and family history were not provided. On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot number: U6745AA and expiry date: 06-Oct-2021) via intramuscular route in the left deltoid for prophylactic vaccination. It was case of an actual medication error due to expired vaccine used (latency: same day). It was reported "Caller asking what they should do, is there a possibility that it is still good and when is it okay to administer another dose." At the time of reporting, no adverse event was reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Expired product administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1718519

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U6745AA

gering
Staat
WA
Alter
20,0
Geschlecht
M
Eingang
21.09.2021
Impfdatum
-
Beginn
-
Tage bis Beginn
-
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Incorrect route of product administration No adverse event

Symptomtext

menactra vaccine 0.5ml given through subcutaneous route/ no AE; Initial information regarding an unsolicited valid non serious case was received from pharmacist and consumer/ non-health professional . This case involves a 20-year-old male patient who received MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA] via subcutaneous route (incorrect route of product administration ). Patient medical history, past medical treatment, vaccination, family history and concomitant medication were not provided. On an unknown date, the patient received a 0.5 mL dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [frequency: once, dose: 0.25 mL to 2 mL for vaccines or 0.1 mL for TB skin test, strength: 0.5 mL, lot U6745AA, expiry date: 06-Oct-2021] via subcutaneous route at an left tricep for prophylactic vaccination. This was actual medication error case due to inappropriate route of vaccination (latency: same day). The Reporter reported "MENACTRA vaccine was given to a patient using the subcutaneous route. patient age less than 1 year enter as 2month, 4month, etc. many pediatric vaccines need month for age 20 years old". At the time of this report the patient was fine and had no adverse events after the vaccination. At time of reporting, the outcome was unknown for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Incorrect route of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1230188

SANOFI PASTEUR · MENINGOCOCCAL CONJUGATE (MENACTRA) · Charge U6745AA

gering
Staat
UT
Alter
12,0
Geschlecht
M
Eingang
19.04.2021
Impfdatum
27.10.2020
Beginn
27.11.2020
Tage bis Beginn
31,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Tic

Symptomtext

Neck tic 1 month post vaccination

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tic
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Asthma
Andere Medikamente
Unknown
Allergien
NKDA
Vorherige Impfungen
Neck tic, 8 years old, 12/29/2016, Flu, FluZone